Press Releases July 31, 2026 07:59 AM

Acorn – Provider of Monitoring and Control Solutions for Mission-Critical Assets Hosts Q2 Earnings Call Thursday Aug. 6th at 11am ET

Acorn Energy Announces Q2 2026 Earnings Call and Discusses Monitoring Solutions for Critical Infrastructure

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
ACFN

Acorn Energy, Inc., through its subsidiary OmniMetrix, will report its Q2 2026 earnings and hold a conference call on August 6th. The company specializes in wireless remote monitoring and control solutions for critical infrastructure such as generators, gas pipelines, cell towers, and data centers, serving commercial, governmental, and residential customers.

Acorn – Provider of Monitoring and Control Solutions for Mission-Critical Assets Hosts Q2 Earnings Call Thursday Aug. 6th at 11am ET
ACFN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Acorn Energy will announce Q2 2026 results and host an earnings call for investors on August 6th.
  • OmniMetrix, Acorn's 99%-owned subsidiary, provides remote monitoring and control technologies for mission-critical assets including cell towers, generators, and pipelines.
  • OmniMetrix recently expanded its product line to include infrastructure security solutions for telecom, data centers, and utility networks, supporting diverse sectors such as energy, healthcare, manufacturing, and government.

WILMINGTON, Del., July 31, 2026 (GLOBE NEWSWIRE) -- Acorn Energy, Inc. (Nasdaq: ACFN), provider of remote monitoring and control solutions for generators, gas pipelines, cell tower campuses and other critical infrastructure, will report its second quarter 2026 results premarket on Thursday, August 6th and host a conference call at 11:00 a.m. ET.

Jan Loeb, President & CEO, and Tracy Clifford, CFO & COO of OmniMetrix, will answer investor questions following prepared remarks. All investors are encouraged to participate.

Conference Call & ReplayDate/Time:  Thursday, August 6th at 11:00am ETDial-in Number:  1-844-834-0644 or 1-412-317-5190 (Int'l)Replay/Transcript:  Audio replay and transcript to be posted online hereQuestions may also be submitted via email to:  [email protected]   

About Acorn (www.acornenergy.com) and OmniMetrixTM (www.omnimetrix.net)
Acorn’s 99%-owned OmniMetrix subsidiary is a pioneering leader in wireless remote monitoring and control solutions for critical infrastructure assets including standby generators, cell tower campuses, gas pipelines, data centers and utility networks. OmniMetrix has also recently launched a product line that provides cutting-edge infrastructure security solutions for cell towers, data centers and utility networks. OmniMetrix serves tens of thousands of commercial and residential endpoints, including over 25 Fortune/Global 500 companies in sectors including telecom, manufacturing, healthcare, data centers, retail, public transportation, energy distribution and government facilities, as well as residential customers through generator dealers.

OmniMetrix’s industry-leading, cost-effective solutions make critical systems more reliable, provide security, and can also enable automated “demand response” electric grid support via enrolled backup generators.

Engage With Us
X: @Acorn_IR and @OmniMetrixStockTwits: @Acorn_Energy  

Investor Relations Contacts
Catalyst IR
William Jones, 267-987-2082
David Collins, 212-924-9800
[email protected]


Risks

  • Market acceptance and integration of new infrastructure security products remain uncertain, impacting future revenue growth.
  • Dependence on large commercial and government clients could lead to revenue fluctuations if contract renewals do not occur.
  • Technological challenges and competition within the critical infrastructure monitoring industry might affect the company's market position and profitability.

More from Press Releases

BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid Sep 14, 2026 Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings Sep 14, 2026 Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results Sep 14, 2026 Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial Sep 14, 2026 Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update Sep 14, 2026